麻醉气体市场：按产品类型、麻醉气体、最终用户、地区 - 规模、份额、展望、机会分析，2022-2028 年

称为吸入麻醉药（例如，异氟烷、七氟烷、地氟烷、氟烷、一氧化二氮）的麻醉气体是术前镇静和围手术期静脉麻醉剂（例如咪达唑仑、异丙酚）的辅助麻醉。作为主要维持疗法使用。

市场动态

在预测期内，慢性病患病率增加、老年（老年人）人口增加、麻醉气体需求增加、手术期间麻醉使用增加、全球外科手术数量增加。是预计将推动麻醉气体市场增长的主要因素。

例如，2022 年 2 月，Sedana Medical 宣布在德国推出 Sedaconda（异氟醚）。 Sedaconda（异氟醚）通过医疗设备 Sedaconda ACD（麻醉保护装置）输送，是唯一获准用于重症监护的吸入镇静疗法。 Sedaconda 于 2021 年 7 月获得欧洲 DCP 批准。

这项研究的主要特点

• 本报告对全球麻醉气体市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2028) 的市场规模和復合年增长率 (CAGR%)。.
• 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 它根据以下参数介绍了全球麻醉气体市场的主要参与者，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
• 本研究涵盖的主要公司包括百特、艾伯维公司、Piramal Enterprises Ltd.、Fresenius SE & Co. KgaA、Dragerwerk AG & Co. KgaA、GE Healthcare 和 Mindray Medical International Limited。等等。
• 这份报告中的见解将使营销人员和企业高管能够就他们未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 《全球麻醉气体市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球麻醉气体市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 麻醉气体市场概况
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 麻醉气体的需求和使用量增加
  • 麻醉气体的副作用
  • 手术次数增加
• 影响分析
• 主要亮点
• 监管情景
• 产品发布和批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球麻醉气体市场 - 冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学特征
• 供应方和需求方分析
• 经济影响

第 5 章按产品类型分列的全球麻醉气体市场，2017-2028

• 麻醉气体
• 汽化器装置

第 6 章。全球麻醉气体市场，按麻醉气体分类，2017-2028

• 地氟醚
• 七氟醚
• 异氟醚
• 一氧化二氮
• 其他麻醉气体

第 7 章全球麻醉气体市场：按最终用户分类，2017-2028

• 医院
• 门诊手术中心

第 8 章按地区分列的全球麻醉气体市场，2017-2028

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地方

第9章竞争格局

• Baxter
• AbbVie Inc.
• Piramal Enterprises Ltd.
• Fresenius SE & Co. KgaA
• Dragerwerk AG & Co. KgaA
• GE Healthcare
• Mindray Medical International Limited

第 10 章

• 调查方法介绍
• 关于出版商

Anesthetic gases (isoflurane, sevoflurane, desflurane, halothane, and nitrous oxide, among others), also known as inhaled anesthetics, are administered as a primary therapy for preoperative sedation and adjunctive anesthesia maintenance to intravenous (IV) anesthetic agents (such as midazolam and propofol) in the perioperative setting.

Market Dynamics:

Increase in prevalence of chronic diseases, increase in geriatric (aging) population, rise in demand for anesthesia gases, increase in use of anesthesia during surgeries, and rise in number of surgical procedures around the world are major factors expected to propel growth of the global anesthesia gases market during the forecast period.

For instance, in February 2022, Sedana Medical announced the launch of Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane), delivered via medical device Sedaconda ACD (Anaesthetic Conserving Device), is the only approved inhaled sedation therapy for use during intensive care. Sedaconda received European DCP approval in July 2021.

Key features of the study:

• This report provides in-depth analysis of the global anesthesia gases market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anesthesia gases market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Baxter, AbbVie Inc., Piramal Enterprises Ltd., Fresenius SE & Co. KgaA, Dragerwerk AG & Co. KgaA, GE Healthcare, and Mindray Medical International Limited, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anesthesia gases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anesthesia gases market.

Detailed Segmentation:

• Global Anesthesia Gases Market, By Product Type:
  • Anesthesia Gases
  • Vaporizer Devices
• Global Anesthesia Gases Market, By Anesthesia Gases:
  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Nitrous Oxide
  • Other Anesthesia Gases
• Global Anesthesia Gases Market, By End User:
  • Hospital
  • Ambulatory Surgical Centers
• Global Anesthesia Gases Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Baxter
  • AbbVie Inc.
  • Piramal Enterprises Ltd.
  • Fresenius SE & Co. KgaA
  • Dragerwerk AG & Co. KgaA
  • GE Healthcare
  • Mindray Medical International Limited

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Anesthesia Gases
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in demand for or use of anesthesia gases
  • Side effects of anesthesia gases
  • Increase in number of surgical procedures
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Anesthesia Gases Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Anesthesia Gases Market, By Product Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Anesthesia Gases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Vaporizer Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Anesthesia Gases Market, By Anesthesia Gases, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Desflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Sevoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Isoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Nitrous Oxide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Anesthesia Gases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Anesthesia Gases Market, By End User, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Anesthesia Gases Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Baxter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Piramal Enterprises Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & Co. KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dragerwerk AG & Co. KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us